William Blair Investment Management LLC Sells 4,375,246 Shares of Acadia Healthcare Company, Inc. $ACHC

William Blair Investment Management LLC trimmed its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 99.5% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 23,309 shares of the company’s stock after selling 4,375,246 shares during the quarter. William Blair Investment Management LLC’s holdings in Acadia Healthcare were worth $529,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd lifted its position in shares of Acadia Healthcare by 11,218.2% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock valued at $38,000 after acquiring an additional 1,234 shares during the period. CWM LLC lifted its position in shares of Acadia Healthcare by 105.1% during the 2nd quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after acquiring an additional 1,349 shares during the period. Covestor Ltd lifted its position in shares of Acadia Healthcare by 56.0% during the 1st quarter. Covestor Ltd now owns 2,262 shares of the company’s stock valued at $69,000 after acquiring an additional 812 shares during the period. Signaturefd LLC lifted its position in shares of Acadia Healthcare by 1,451.7% during the 2nd quarter. Signaturefd LLC now owns 5,043 shares of the company’s stock valued at $114,000 after acquiring an additional 4,718 shares during the period. Finally, Parallel Advisors LLC lifted its position in shares of Acadia Healthcare by 1,120.3% during the 2nd quarter. Parallel Advisors LLC now owns 5,174 shares of the company’s stock valued at $117,000 after acquiring an additional 4,750 shares during the period.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Raymond James Financial boosted their price target on Acadia Healthcare from $26.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, October 3rd. UBS Group lowered their price target on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Royal Bank Of Canada lowered their price target on Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Cowen reissued a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $25.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 7th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $35.09.

Acadia Healthcare Trading Down 0.9%

Shares of ACHC stock opened at $23.96 on Tuesday. The firm has a market capitalization of $2.21 billion, a P/E ratio of 15.87, a P/E/G ratio of 4.79 and a beta of 0.90. Acadia Healthcare Company, Inc. has a twelve month low of $17.13 and a twelve month high of $54.15. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock’s fifty day simple moving average is $23.21 and its 200 day simple moving average is $23.13.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same quarter in the previous year, the company posted $0.91 EPS. The business’s revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.